Fig. 5.
Efficacy of different threats against B. melitensis. CFU of B. melitensis as treated by (A) untreated samples, (B) nanocarrier, (C)free rifampicin, and (D) loaded rifampicin. ***P=0.0006; ****P<0.0001
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.